Clinical trial
Safety of Estrogens in Lupus Erythematosus - National Assessment (SELENA): Oral Contraceptives
NCT00000420 is registered in ClinicalTrials.gov with NYU Langone Health as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Safety of Estrogens in Lupus Erythematosus - National Assessment (SELENA): Oral Contraceptives
- Lead sponsor
- NYU Langone Health
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- June 30, 1997
- Completion date
- August 31, 2003
- Enrollment
- 350
- Sites
- 15
Conditions
As the registry lists them; a condition with its own page is linked.
systemic lupus erythematosus